Share this article
Share this article
SANTA ANA, Calif., April 21, 2021 /PRNewswire/ Johnson & Johnson Vision , a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies , today announced the FDA 510(k) clearance and CE mark of its next-generation phacoemulsification innovation, the VERITAS™ Vision System
1. The high-performance phacoemulsification system features technologies that allow surgeons to guide through any lens density with less surge and more stability. The new system also provides advancements in ergonomics to further enhance usability during cataract surgery.
(PRNewsfoto/Johnson & Johnson Vision)
More than 90% of people develop cataracts by the age of 65,
2 and cataract surgery is one of the most common outpatient procedures performed today with a success rate of approximately 98%.
Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS Vision System
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson Vision Receives Approval of World s First and Only Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE® Theravision™ with Ketotifen
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.